Energy and Commerce Hearing on drug pricing program

Typically, members of the U.S. House Energy and Commerce committee handle energy matters.

But remember, part of the committee’s name also focuses on Commerce and Wednesday, Oklahoma Congressman Markwayne Mullin and others on the committee will delve into a drug pricing program.

“Opportunities to Improve the 340B Drug Pricing Program” is the name of the hearing that will begin at 9 a.m. central time on capitol hill.

Four witnesses will testify including Debra Draper, Director of the Health Care Team at the U.S. Government Accountability Office; Dr. Frederick Cerise who is President and CEO of Parkland Hospital in Dallas; Dr. Charles Daniels who is Pharmacist-in-Chief and Associate Dean at the University of California in San Diego; and Dr. Debra Patt, chair of the U.S. Oncology Network Pathways Taskforce for Breast Cancer at Texas Oncology.